2d
Daily Maverick on MSNNew chronic kidney disease treatments show promise, but are expensive and inaccessibleWhile the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
9d
HealthDay on MSNGLP-1 Drugs Improve Outlook For Kidney TransplantsGLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...
The study focused on why people with severe high blood pressure often develop thickened arteries and small blood vessels in ...
Doctors have traditionally advised patients to take blood pressure medication in the morning because blood pressure tends to ...
9d
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
NEW YORK, March 5, 2025 /PRNewswire/ -- Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived ...
THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results